111 related articles for article (PubMed ID: 37678474)
1. Nose-to-brain delivery of 18β-Glycyrrhetinic acid using optimized lipid nanocapsules: A novel alternative treatment for Alzheimer's disease.
Gad SR; El-Gogary RI; George MY; Hathout RM
Int J Pharm; 2023 Oct; 645():123387. PubMed ID: 37678474
[TBL] [Abstract][Full Text] [Related]
2. Nose to brain delivery of melatonin lipidic nanocapsules as a promising post-ischemic neuroprotective therapeutic modality.
Bseiso EA; AbdEl-Aal SA; Nasr M; Sammour OA; El Gawad NAA
Drug Deliv; 2022 Dec; 29(1):2469-2480. PubMed ID: 35892291
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer's disease models.
Bernardi A; Frozza RL; Meneghetti A; Hoppe JB; Battastini AM; Pohlmann AR; Guterres SS; Salbego CG
Int J Nanomedicine; 2012; 7():4927-42. PubMed ID: 23028221
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of 18β-glycyrrhetinic acid against bisphenol A-induced neurotoxicity in rats: involvement of neuronal apoptosis, endoplasmic reticulum stress and JAK1/STAT1 signaling pathway.
Caglayan C; Kandemir FM; Ayna A; Gür C; Küçükler S; Darendelioğlu E
Metab Brain Dis; 2022 Aug; 37(6):1931-1940. PubMed ID: 35699857
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effects of 18β-glycyrrhetinic acid following oxidative and neuronal damage in brain tissue caused by global cerebral ischemia/reperfusion in a C57BL/J6 mouse model.
Oztanir MN; Ciftci O; Cetin A; Durak MA; Basak N; Akyuva Y
Neurol Sci; 2014 Aug; 35(8):1221-8. PubMed ID: 24554419
[TBL] [Abstract][Full Text] [Related]
6. Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.
Ashour AA; El-Kamel AH; Abdelmonsif DA; Khalifa HM; Ramadan AA
Int J Nanomedicine; 2021; 16():8013-8033. PubMed ID: 34916792
[TBL] [Abstract][Full Text] [Related]
7. Intranasal lipid nanocapsules for systemic delivery of nimodipine into the brain: In vitro optimization and in vivo pharmacokinetic study.
Mohsen K; Azzazy HME; Allam NK; Basalious EB
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111236. PubMed ID: 32806316
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Effect of Saroglitazar on Scopolamine-Induced Alzheimer's in Rats: Insights into the Underlying Mechanisms.
Sandeep Ganesh G; Konduri P; Kolusu AS; Namburi SV; Chunduru BTC; Nemmani KVS; Samudrala PK
ACS Chem Neurosci; 2023 Sep; 14(18):3444-3459. PubMed ID: 37669120
[TBL] [Abstract][Full Text] [Related]
10. 18-β Glycyrrhetinic acid alleviates 2-acetylaminofluorene-induced hepatotoxicity in Wistar rats: Role in hyperproliferation, inflammation and oxidative stress.
Hasan SK; Khan R; Ali N; Khan AQ; Rehman MU; Tahir M; Lateef A; Nafees S; Mehdi SJ; Rashid S; Shahid A; Sultana S
Hum Exp Toxicol; 2015 Jun; 34(6):628-41. PubMed ID: 25352648
[TBL] [Abstract][Full Text] [Related]
11.
Hosseini M; Mansouritorghabeh F; Beheshti F; Shahidpour F; Forouzanfar F; Rajabian A
Cent Nerv Syst Agents Med Chem; 2023; 23(2):109-118. PubMed ID: 37563815
[TBL] [Abstract][Full Text] [Related]
12. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
[TBL] [Abstract][Full Text] [Related]
13. Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by β-amyloid
Giacomeli R; de Gomes MG; Reolon JB; Haas SE; Colomé LM; Jesse CR
Behav Brain Res; 2020 Jul; 390():112696. PubMed ID: 32417280
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
[TBL] [Abstract][Full Text] [Related]
15. Nose to brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and pharmacokinetic study.
Ibrahim MM; Basalious EB; El-Nabarawi MA; Makhlouf AI; Sayyed ME; Ibrahim IT
Drug Deliv Transl Res; 2024 Feb; ():. PubMed ID: 38376620
[TBL] [Abstract][Full Text] [Related]
16. Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.
Sun R; Zhang A; Ge Y; Gou J; Yin T; He H; Wang Y; Zhang G; Kong J; Shang L; Tao X; Zhang Y; Tang X
Expert Opin Drug Deliv; 2020 Sep; 17(9):1305-1320. PubMed ID: 32538226
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARγ and Nrf2: Protective effect of 18β-Glycyrrhetinic acid.
Mahmoud AM; Hussein OE; Hozayen WG; Abd El-Twab SM
Chem Biol Interact; 2017 May; 270():59-72. PubMed ID: 28414158
[TBL] [Abstract][Full Text] [Related]
18. 18β-Glycyrrhetinic acid protects against methotrexate-induced kidney injury by up-regulating the Nrf2/ARE/HO-1 pathway and endogenous antioxidants.
Abd El-Twab SM; Hozayen WG; Hussein OE; Mahmoud AM
Ren Fail; 2016 Oct; 38(9):1516-1527. PubMed ID: 27499091
[TBL] [Abstract][Full Text] [Related]
19. Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential
Amara RO; Ramadan AA; El-Moslemany RM; Eissa MM; El-Azzouni MZ; El-Khordagui LK
Int J Nanomedicine; 2018; 13():4493-4505. PubMed ID: 30122922
[TBL] [Abstract][Full Text] [Related]
20. The Protective Role of Selenium on Scopolamine-Induced Memory Impairment, Oxidative Stress, and Apoptosis in Aged Rats: The Involvement of TRPM2 and TRPV1 Channels.
Balaban H; Nazıroğlu M; Demirci K; Övey İS
Mol Neurobiol; 2017 May; 54(4):2852-2868. PubMed ID: 27021021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
